Table 2 Late toxicities after anti-CD45... | American Society of Hematology

Table 2

Late toxicities after anti-CD45 PRIT using 400 μCi or 800 μCi ²¹³Bi-DOTA-biotin

WBC, 1000/μL	Platelets, 1000/μL	Hemoglobin, g/dL	Hematocrit, %	Neutrophils, μL	BUN, mg/dL	Creatinine, mg/dL	ALP, U/L	ALT, U/L	AST, U/L
14.2 ± 1.9	1732 ± 149	14.4 ± 1.2	48.0 ± 2.4	5820 ± 355	25.7 ± 8.4	0.48 ± 0.01	69.7 ± 21	122 ± 84	215 ± 94
12.2 ± 2.0	1152 ± 171	15.0 ± 0.2	48.8 ± 0.8	5835 ± 630	27.7 ± 3.3	0.48 ± 0.04	90.8 ± 41	389 ± 530	214 ± 170
9.9 ± 2.0	983 ± 407	13.6 ± 0.7	45.7 ± 2.0	3185 ± 1280	33.5 ± 9.7	0.57 ± 0.10	119 ± 63	371 ± 480	385 ± 290

WBC, 1000/μL	Platelets, 1000/μL	Hemoglobin, g/dL	Hematocrit, %	Neutrophils, μL	BUN, mg/dL	Creatinine, mg/dL	ALP, U/L	ALT, U/L	AST, U/L
14.2 ± 1.9	1732 ± 149	14.4 ± 1.2	48.0 ± 2.4	5820 ± 355	25.7 ± 8.4	0.48 ± 0.01	69.7 ± 21	122 ± 84	215 ± 94
12.2 ± 2.0	1152 ± 171	15.0 ± 0.2	48.8 ± 0.8	5835 ± 630	27.7 ± 3.3	0.48 ± 0.04	90.8 ± 41	389 ± 530	214 ± 170
9.9 ± 2.0	983 ± 407	13.6 ± 0.7	45.7 ± 2.0	3185 ± 1280	33.5 ± 9.7	0.57 ± 0.10	119 ± 63	371 ± 480	385 ± 290